Cargando…

The Association Between Illicit Drug Use and the Duration of Renal Replacement Therapy in Patients With Acute Kidney Injury From Severe Rhabdomyolysis

Background and Aims: Acute kidney injury is a known complication of severe rhabdomyolysis. In patients who present to hospital with rhabdomyolysis, illicit drug use is associated with a higher risk of acute kidney injury needing renal replacement therapy (RRT), independent of the peak serum creatine...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Andy K. H., Azraai, Meor, Pham, Jeanette H., Looi, Wenye F., Bennett, Caitriona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680872/
https://www.ncbi.nlm.nih.gov/pubmed/33240909
http://dx.doi.org/10.3389/fmed.2020.588114
_version_ 1783612520523628544
author Lim, Andy K. H.
Azraai, Meor
Pham, Jeanette H.
Looi, Wenye F.
Bennett, Caitriona
author_facet Lim, Andy K. H.
Azraai, Meor
Pham, Jeanette H.
Looi, Wenye F.
Bennett, Caitriona
author_sort Lim, Andy K. H.
collection PubMed
description Background and Aims: Acute kidney injury is a known complication of severe rhabdomyolysis. In patients who present to hospital with rhabdomyolysis, illicit drug use is associated with a higher risk of acute kidney injury needing renal replacement therapy (RRT), independent of the peak serum creatine kinase level. The aim of this study was to assess if RRT duration and renal outcomes were also worse in illicit drug use-associated rhabdomyolysis. Methods: We conducted a cohort study of adult patients who presented to Monash Health (Jan 2011–June 2020) with rhabdomyolysis and required RRT. Patients with isolated myocardial injury and cardiac arrest were excluded. We used survival analysis to examine the time to RRT independence, utilizing the Fine-Gray competing risks regression and death as the competing event. A subdistribution hazard ratio (SHR) < 1.0 represents a relatively greater duration of RRT and a worse outcome. Results: We included 101 patients with a mean age of 58 years, of which 17% were cases associated with illicit drug use. The median peak creatine kinase level was 5,473 U/L (interquartile range, 1,795–17,051 U/L). Most patients (79%) initiated RRT within 72 h of admission, at a median serum creatinine of 537 μmol/L (interquartile range, 332–749 μmol/L). In the competing risks analysis, the estimated SHR was 1.48 (95% CI: 0.78–2.84, P = 0.23) for illicit drug use, 0.87 (95% CI: 0.76–0.99, P = 0.041) for the log-transformed peak creatine kinase, and 0.41 (95% CI: 0.25–0.67, P < 0.001) for sepsis. A 50% cumulative incidence of RRT independence occurred at 11 days (95% CI: 8–16 days). Only 5% of patients remained on RRT at 3 months. Conclusion: In rhabdomyolysis-associated acute kidney injury, it is unlikely that patients with illicit drug use-associated rhabdomyolysis require a longer duration of RRT compared to patients with rhabdomyolysis from other causes.
format Online
Article
Text
id pubmed-7680872
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-76808722020-11-24 The Association Between Illicit Drug Use and the Duration of Renal Replacement Therapy in Patients With Acute Kidney Injury From Severe Rhabdomyolysis Lim, Andy K. H. Azraai, Meor Pham, Jeanette H. Looi, Wenye F. Bennett, Caitriona Front Med (Lausanne) Medicine Background and Aims: Acute kidney injury is a known complication of severe rhabdomyolysis. In patients who present to hospital with rhabdomyolysis, illicit drug use is associated with a higher risk of acute kidney injury needing renal replacement therapy (RRT), independent of the peak serum creatine kinase level. The aim of this study was to assess if RRT duration and renal outcomes were also worse in illicit drug use-associated rhabdomyolysis. Methods: We conducted a cohort study of adult patients who presented to Monash Health (Jan 2011–June 2020) with rhabdomyolysis and required RRT. Patients with isolated myocardial injury and cardiac arrest were excluded. We used survival analysis to examine the time to RRT independence, utilizing the Fine-Gray competing risks regression and death as the competing event. A subdistribution hazard ratio (SHR) < 1.0 represents a relatively greater duration of RRT and a worse outcome. Results: We included 101 patients with a mean age of 58 years, of which 17% were cases associated with illicit drug use. The median peak creatine kinase level was 5,473 U/L (interquartile range, 1,795–17,051 U/L). Most patients (79%) initiated RRT within 72 h of admission, at a median serum creatinine of 537 μmol/L (interquartile range, 332–749 μmol/L). In the competing risks analysis, the estimated SHR was 1.48 (95% CI: 0.78–2.84, P = 0.23) for illicit drug use, 0.87 (95% CI: 0.76–0.99, P = 0.041) for the log-transformed peak creatine kinase, and 0.41 (95% CI: 0.25–0.67, P < 0.001) for sepsis. A 50% cumulative incidence of RRT independence occurred at 11 days (95% CI: 8–16 days). Only 5% of patients remained on RRT at 3 months. Conclusion: In rhabdomyolysis-associated acute kidney injury, it is unlikely that patients with illicit drug use-associated rhabdomyolysis require a longer duration of RRT compared to patients with rhabdomyolysis from other causes. Frontiers Media S.A. 2020-11-09 /pmc/articles/PMC7680872/ /pubmed/33240909 http://dx.doi.org/10.3389/fmed.2020.588114 Text en Copyright © 2020 Lim, Azraai, Pham, Looi and Bennett. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Lim, Andy K. H.
Azraai, Meor
Pham, Jeanette H.
Looi, Wenye F.
Bennett, Caitriona
The Association Between Illicit Drug Use and the Duration of Renal Replacement Therapy in Patients With Acute Kidney Injury From Severe Rhabdomyolysis
title The Association Between Illicit Drug Use and the Duration of Renal Replacement Therapy in Patients With Acute Kidney Injury From Severe Rhabdomyolysis
title_full The Association Between Illicit Drug Use and the Duration of Renal Replacement Therapy in Patients With Acute Kidney Injury From Severe Rhabdomyolysis
title_fullStr The Association Between Illicit Drug Use and the Duration of Renal Replacement Therapy in Patients With Acute Kidney Injury From Severe Rhabdomyolysis
title_full_unstemmed The Association Between Illicit Drug Use and the Duration of Renal Replacement Therapy in Patients With Acute Kidney Injury From Severe Rhabdomyolysis
title_short The Association Between Illicit Drug Use and the Duration of Renal Replacement Therapy in Patients With Acute Kidney Injury From Severe Rhabdomyolysis
title_sort association between illicit drug use and the duration of renal replacement therapy in patients with acute kidney injury from severe rhabdomyolysis
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680872/
https://www.ncbi.nlm.nih.gov/pubmed/33240909
http://dx.doi.org/10.3389/fmed.2020.588114
work_keys_str_mv AT limandykh theassociationbetweenillicitdruguseandthedurationofrenalreplacementtherapyinpatientswithacutekidneyinjuryfromsevererhabdomyolysis
AT azraaimeor theassociationbetweenillicitdruguseandthedurationofrenalreplacementtherapyinpatientswithacutekidneyinjuryfromsevererhabdomyolysis
AT phamjeanetteh theassociationbetweenillicitdruguseandthedurationofrenalreplacementtherapyinpatientswithacutekidneyinjuryfromsevererhabdomyolysis
AT looiwenyef theassociationbetweenillicitdruguseandthedurationofrenalreplacementtherapyinpatientswithacutekidneyinjuryfromsevererhabdomyolysis
AT bennettcaitriona theassociationbetweenillicitdruguseandthedurationofrenalreplacementtherapyinpatientswithacutekidneyinjuryfromsevererhabdomyolysis
AT limandykh associationbetweenillicitdruguseandthedurationofrenalreplacementtherapyinpatientswithacutekidneyinjuryfromsevererhabdomyolysis
AT azraaimeor associationbetweenillicitdruguseandthedurationofrenalreplacementtherapyinpatientswithacutekidneyinjuryfromsevererhabdomyolysis
AT phamjeanetteh associationbetweenillicitdruguseandthedurationofrenalreplacementtherapyinpatientswithacutekidneyinjuryfromsevererhabdomyolysis
AT looiwenyef associationbetweenillicitdruguseandthedurationofrenalreplacementtherapyinpatientswithacutekidneyinjuryfromsevererhabdomyolysis
AT bennettcaitriona associationbetweenillicitdruguseandthedurationofrenalreplacementtherapyinpatientswithacutekidneyinjuryfromsevererhabdomyolysis